DK1030686T3 - Lyofilisat af et lipidkompleks af vanduopløselige porphyrimer - Google Patents

Lyofilisat af et lipidkompleks af vanduopløselige porphyrimer

Info

Publication number
DK1030686T3
DK1030686T3 DK98903356T DK98903356T DK1030686T3 DK 1030686 T3 DK1030686 T3 DK 1030686T3 DK 98903356 T DK98903356 T DK 98903356T DK 98903356 T DK98903356 T DK 98903356T DK 1030686 T3 DK1030686 T3 DK 1030686T3
Authority
DK
Denmark
Prior art keywords
porphyrimers
lyophilisate
insoluble
water
lipid complex
Prior art date
Application number
DK98903356T
Other languages
Danish (da)
English (en)
Inventor
Mathew Cherian
Shireesh Prakash Apte
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1030686T3 publication Critical patent/DK1030686T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK98903356T 1997-01-28 1998-01-28 Lyofilisat af et lipidkompleks af vanduopløselige porphyrimer DK1030686T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78956697A 1997-01-28 1997-01-28

Publications (1)

Publication Number Publication Date
DK1030686T3 true DK1030686T3 (da) 2004-04-13

Family

ID=25148009

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98903356T DK1030686T3 (da) 1997-01-28 1998-01-28 Lyofilisat af et lipidkompleks af vanduopløselige porphyrimer

Country Status (9)

Country Link
EP (1) EP1030686B1 (ja)
JP (1) JP2001511128A (ja)
AT (1) ATE261736T1 (ja)
AU (1) AU6015298A (ja)
DE (1) DE69822496T2 (ja)
DK (1) DK1030686T3 (ja)
ES (1) ES2218805T3 (ja)
PT (1) PT1030686E (ja)
WO (1) WO1998032463A2 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2005084665A1 (ja) * 2004-03-04 2005-09-15 Makoto Yuasa 金属ポルフィリン錯体包埋ニオソーム、その製造法およびこれを利用する医薬
JP4591820B2 (ja) * 2005-01-31 2010-12-01 株式会社ケムコ 化学発光試薬
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP5143131B2 (ja) 2006-05-30 2013-02-13 インターシア セラピューティクス,インコーポレイティド 浸透圧送出システムの二片構成内部チャネル型の流れモジュレータ
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
MX2009011123A (es) 2007-04-23 2009-11-02 Intarcia Therapeutics Inc Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
NZ598686A (en) 2009-09-28 2014-05-30 Intarcia Therapeutics Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
EP3019559A4 (en) 2013-08-22 2017-04-05 Sony Corporation Water soluble fluorescent or colored dyes and methods for their use
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
CN109071961B (zh) 2016-05-11 2021-04-27 索尼公司 超亮二聚或聚合染料
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
US20200222554A1 (en) * 2017-10-05 2020-07-16 Sony Corporation Programmable dendritic drugs
EP3710062A1 (en) 2017-11-16 2020-09-23 Sony Corporation Programmable polymeric drugs
WO2019182765A1 (en) 2018-03-19 2019-09-26 Sony Corporation Use of divalent metals for enhancement of fluorescent signals
WO2021062176A2 (en) 2019-09-26 2021-04-01 Sony Corporation Polymeric tandem dyes with linker groups

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer

Also Published As

Publication number Publication date
ATE261736T1 (de) 2004-04-15
AU6015298A (en) 1998-08-18
EP1030686B1 (en) 2004-03-17
PT1030686E (pt) 2004-06-30
JP2001511128A (ja) 2001-08-07
EP1030686A2 (en) 2000-08-30
ES2218805T3 (es) 2004-11-16
DE69822496D1 (de) 2004-04-22
WO1998032463A2 (en) 1998-07-30
WO1998032463A3 (en) 1998-10-22
DE69822496T2 (de) 2005-03-03

Similar Documents

Publication Publication Date Title
DK1030686T3 (da) Lyofilisat af et lipidkompleks af vanduopløselige porphyrimer
BR9612051A (pt) Implante médico
DE69531701D1 (de) Sphingosome mit verbesserter arzneistoffabgage
DE60115029D1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE69616523T2 (de) Verfahren zur baladung von lipidvesikeln
DK0914144T3 (da) Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi
HUP0001266A2 (hu) Nagyon kis oldhatóságú platinakomplexek lipidkomplexei és liposzómái
IL112667A (en) 6-substituted derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
NO20004419D0 (no) Ny anvendelse
TR200001147T2 (tr) Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı
DK0539479T3 (da) Heterocykliske forbindelser
ATE103804T1 (de) Pharmazeutische praeparate.
DE69817379D1 (de) Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
DE69928523D1 (de) Verotoxin b untereinheit zur immunisierunug
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia
UA30911A (uk) Спосіб поліхіміотерапії хворих деструктивним туберкульозом легень
UA30011A (uk) Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань
UA22085A (uk) Спосіб рекоhструкції біфуркації трахеї після її широкої резекції